Eric J Loumeau insider trades: Anaptysbio (ANAB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | ANAB | ↓ Sell | 9,639 | $45.56 | $439K | Direct | Jan 8, 2026 (1d) |
| Jan 5, 2026 | ANAB | ↓ Sell | 2,983 | $43.26 | $129K | Direct | Jan 6, 2026 (1d) |
| Dec 22, 2025 | ANAB | ↓ Sell | 10,000 | $51.00 | $510K | Direct | Dec 23, 2025 (1d) |
| Dec 18, 2025 | ANAB | ↓ Sell | 22,641 | $45.38 | $1.0M | Direct | Dec 18, 2025 (0d) |
| Sep 30, 2025 | ANAB | ↓ Sell | 8,240 | $29.00 | $239K | Direct | Oct 1, 2025 (1d) |
| Sep 17, 2024 | ANAB | ↓ Sell | 12,500 | $39.40 | $492K | Direct | Sep 17, 2024 (0d) |
| Feb 16, 2024 | ANAB | ↓ Sell | 5,000 | $25.00 | $125K | Direct | Feb 21, 2024 (5d) |
| Jan 8, 2024 | ANAB | ↓ Sell | 2,305 | $21.81 | $50K | Direct | Jan 9, 2024 (1d) |
| Nov 22, 2023 | ANAB | ↓ Sell | 882 | $14.19 | $13K | Direct | Nov 27, 2023 (5d) |
| Sep 18, 2023 | ANAB | ↓ Sell | 6,000 | $19.37 | $116K | Direct | Sep 18, 2023 (0d) |
| Aug 8, 2022 | ANAB | ↓ Sell | 523 | $25.00 | $13K | Direct | Aug 9, 2022 (1d) |
| Jun 8, 2022 | ANAB | ↓ Sell | 2,500 | $24.00 | $60K | Direct | Jun 10, 2022 (2d) |
| May 18, 2022 | ANAB | ↓ Sell | 1,146 | $20.50 | $23K | Direct | May 20, 2022 (2d) |
| Nov 4, 2021 | ANAB | ↓ Sell | 5,000 | $35.00 | $175K | Direct | Nov 5, 2021 (1d) |
| Feb 12, 2021 | ANAB | ↓ Sell | 10,000 | $35.00 | $350K | Direct | Feb 12, 2021 (0d) |
| Jun 26, 2017 | OTIC | ↓ Sell | 3,522 | $18.59 | $65K | Direct | Jun 27, 2017 (1d) |
| Feb 14, 2007 | HEPH | ↓ Sell | 937 | $5.50 | $5K | Direct | Feb 15, 2007 (1d) |
| Sep 29, 2005 | HEPH | ↓ Sell | 500 | $11.00 | $6K | Direct | Sep 30, 2005 (1d) |
| Sep 26, 2005 | HEPH | ↓ Sell | 1,000 | $10.00 | $10K | Direct | Sep 27, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANAB insiders
Open-market trades in the last 12 months
About Eric J Loumeau's insider trades
Eric J Loumeau is Chief Legal Officer at Anaptysbio (ANAB). Since Sep 26, 2005, Eric has reported no open-market purchases and 19 sales worth $3.8M on SEC Form 4. In the last 12 months: 4 sales ($2.1M).
Their filings also include grants and awards (23 filings), option exercises (15 filings), shares withheld for taxes (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.